Phosphoinositide signaling has long been regarded as a membrane-confined regulatory system; however, emerging evidence reveals a distinct nuclear lipid signaling axis that directly regulates protein stability. A recent study details a previously unrecognized mechanism controlling nuclear factor erythroid 2-related factor 2 (NRF2), demonstrating that oxidative stress induces its stabilization through a nuclear complex composed of type I phosphatidylinositol 4-phosphate 5-kinase γ (PIPKIγ), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and small heat shock protein 27 (HSP27). In this pathway, PIPKIγ generates a stably associated nuclear pool of PtdIns(4,5)P2 on NRF2, promoting HSP27 recruitment and protecting NRF2 from proteasomal degradation, independent of the canonical Kelch-like ECH-associated protein 1 (KEAP1) mechanism. This pathway parallels a nuclear phosphoinositide-dependent stabilization paradigm previously described for tumor protein p53 (p53), in which another 5-kinase, type I phosphatidylinositol 4-phosphate 5-kinase α (PIPKIα), mediates p53 stabilization. The isoform-specific engagement of PIP kinases highlights a fundamental principle of nuclear signaling that enables stress-selective transcriptional regulation, exposing new therapeutic vulnerabilities in cancer.
Tang et al. (Sun,) studied this question.